Capsid Assembly Modulator Pevifoscorvir Sodium Granted FDA Fast Track

Summary: The FDA just gave a special "Fast Track" ticket to a new medicine called pevifoscorvir sodium. This drug is designed to fight chronic Hepatitis B, which is a serious liver infection. It works by acting like a wrench in a factory, stopping the virus from building its outer shell and copying itself. Early tests showed the medicine is safe and successfully lowers the amount of virus in the body. Right now, it is in a bigger study called the B-SUPREME trial to see how it compares to an older drug. Doctors are adding more patients to the study to make sure the results are clear, and they expect to have the final answers by 2027.

For more details, see rssapp-renalandurologynews-com at renalandurologynews.com/news/capsid-assembly-modulator-pevifoscorvir-sodium-granted-fda-fast-track/ (opens in new tab)